Member Info for JRDC

Nice spot. I see David Annable - Professional Carpet Cleaner at Supaclean is on the list too - guessing he got the gig to sort Al's living room carpet out.

Is this the surescreen test I presume or what's left of the chinese one? Guess we'll find out at 5.00

Only 90% accurate, even the Innova tests were better than that in the lab. About as much threat to ncyt as Dacia are to Tesla

Another UK contract of some description is certainly coming - they have all these Q machines in place, their current supply of swabs will be used up soon, it's still currently the gold standard other tests are compared to, and as lockdown eases more swabs will be needed. At worst we'll get a similar contract to the first DHSC agreement but I imagine for longer and higher numbers.

Contracts of at least £1m they aren't even bothered to RNS for, it seems only larger contracts will be detailed to markets when allowed. We could be getting several of those a month The fact things are quiet means something is brewing, the only time to worry imo if is they start releasing an RNS for sales numbers they wouldn't have bothered with, but they haven't.

Europe and US are struggling with vaccinations, so while the UK might take the initial batch of LFT, that could open up the use of PCR elsewhere to get economies back up and running.

I've averaged up to £5.50, I think I'll have doubled my money between now and end June

If this drops to £6 or less this week I'll find every penny I can and whack it in for the inevitable rebound. Might even be tempted to sell some Avacta if it reaches a daft number tomorrow and move more here.

If it's a choice between staying closed and folding or being given a way to open, even if not ideal, I think I know what they might go for.

@spart the sp hit £5 in may after 1st small dhsc contract, dropped to £2.00 odd before rising to £4.50 over a few months (which seem like eternity at the time). Then the £150 dhsc contract announced, and it peaked at £12, and now it's sitting at under £8, probably heading for under £7 next week without news. Certainly didn't 5 bag on the news. Markets are brutal imo, potentially a P/e of under 3 over there.

Is it still meant to cost £100bn? We're a major player but even if we 'only' end up with 1% of that over next 2 years it'll be game changing and an SP imo of at least £4 ( purely based on how market has treated Novacyt and their £300m revenue, and excluding ava and other partnerships, and not including BAMS). If the majority of that is coming the way of the consortium... well, I'll need a better calculator

Even so, I can't think of another company making £150m in genuine profit, £100m in cash and a p/e of just 3.5. Could well be 3 or less on Monday as panicked invested who havent done their research leave for odx, avacta or Abingdon. This has a 50% rise written all over it

AlwaysSinking

The chinese LFT has given all LFT tests a bad name- similar to how randex nearly tarnished reputation of PCR. The govt and newspapers will now be having a huge push to reverse that.

This new LFT is more sensitive, and the next gen of tests currently being worked on will be even more so, I can't wait to get back to some sort of normality this year thanks to British engineering, development and cooperation between competitors.

Avacta will earn no where near the percentage nova do on theirs, but will hopefully make up for that in shear numbers, possibly tens of millions a month for the next year or so

I still think there's more to come from nova, this will dip next week which is a fantastic chance to top up and will be back to £10 by end of spring imo

Everyone is holding as many shares as they can in their ISA or sipp and partner's ISA/sipp. Rumours are that CGT could be brought inline with income tax bands (doubling in effect), so you'll be handing large chunks of that lovely profit to Mr tax man when you come to sell (and I imagine you will if this hits £10+ anytime soon) above your allowance.

Good news is if you're an RMS holder - and no doubt soon BRH if you've just invested there - you'll be able to offset your huge losses.

@porky, wouldn't be feasible to test 65m lft and get results back in a meaningful time.

Nova need to continue sideways diversification and make that £100m cash bring in guaranteed £10m+ a year and get their machines installed in as many clinical areas as possible for future use in diagnosis, even if it means taking less favourable terms on actual tests. But GM is a smart chap, I'm sure he's aware of that already and would have known LFT and BAMS were coming

The only risk to PCR really is from mass spectrometry, those maldi tof machines are installed in pretty much every foundation trust and have been part of workflow for well over a decade (sepsis was the main driving force for that). BAMS is still being trialled on bruker hardware and even when approved for diagnostic use, they won't be able to manufacture enough.

I think the US will become a major market for nova.

Going to have a cherry 7up to celebrate.

Hoping we don't get an RNS on Monday, quite like being above £1.50. ha.

Feels like being a kid a few days before xmas

Is it is?

Nice. Maybe one day nova and avacta will both finish blue... Only managed a bit at £7.10, had queued more at £7.00 but didn't quite hit it. I still think this could test £7 again when govt launch the LFT in a week or so before rebounding strongly in march to new highs. But then again, every other price prediction I've had has been wrong ha.

We're barely £3 above what we were in may last year before any dhsc contracts had been signed and any whiff of sales figures. Is £250m+ in sales only worth a £3 uplift? Until indicated otherwise I'm assuming we're still bringing in £10m a month in revenue, exc govt contracts

March will be a good indicator, as wil July when the half year results are given, I'll be holding till then at least. One minor mutation in future could be enough to render every produced LFT and every vaccine useless, all pcr needs is a software change. Absolutely no need to panic imo

Isn't it the highest price that whoever is instigating the takeover paid in last 12 months? If they havent been building up a position then they can offer whatever they want.

Does anyone know of a successful company that does reply to each and every invester enquiry? With NCYT we already know they want to keep investers in the dark, but doesn't seem much different from any other company. Only people who are down are the gamblers who were banking on £500m revenue and phase 2 being activated, not a good way to invest imo.